We should consider continuing medical education in the context of a free economyThe growing criticism of pharmaceutical company funding of CME has rattled both the pharmaceutical industry and many legitimate providers of CME. To recap the recent criticisms: The Special Communication by leaders of academic medicine in JAMA, the Journal of the American Medical Association (Jan. […]
The post Time for a Reappraisal of the “Business�? of CME appeared first on HealthCommentary.